Israel Biotech Fund — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
BiotechHackensack, US
James McGorry(Executive Officer)David Miller(Executive Officer)Daniel Mendelson(Director)Joel Ackerman(Executive Officer, Director)Abba David Poliakoff(Director)Arthur Epker, III(Director)
Board seatDavid Sidransky· per SEC Form D · $14M raise · filed Mar 2015
Orgenesis operates the POCare Platform for developing, scaling, and commercializing advanced cell and gene therapies delivered at the point of care.
BiotechHealthtechMedical DevicesGermantown, US
Etti Hanochi(Director)Yaron Adler(Director)Yachin Yachin(Director)Neil Reithinger(Executive Officer)Vered Caplan(Executive Officer, Director)Ferber Ferber(Executive Officer)
Board seatDavid Sidransky· per SEC Form D · $10M raise · filed Dec 2015
BiotechSan Diego, US
Fred Knoll(Director)Patrick Ostronick(Director)John Brancaccio(Director)Jamie Sulley(Executive Officer, Director)Paul Weiss(Director)Joanne Barsa(Executive Officer)
Board seatDavid Sidransky· per SEC Form D · $800K raise · filed Sep 2015
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.